Form 8-K Inari Medical, Inc. For: Oct 28
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Inari Medical Inc. (NARI) PT Raised to $50 at Truist Securities
October 29, 2024 5:57 AM EDTTruist Securities analyst Richard Newitter raised the price target on Inari Medical Inc. (NASDAQ: NARI) to $50.00 (from $46.00) while maintaining a Hold rating.
The analyst comments "NARI's 3Q profit beat shld help the stock recover a bit (up +9% AMC) some of its recent pullback... More
BTIG Reiterates Buy Rating on Inari Medical Inc. (NARI)
October 29, 2024 5:47 AM EDTBTIG analyst Marie Thibault reiterated a Buy rating and $86.00 price target on Inari Medical Inc. (NASDAQ: NARI).
The analyst comments "Inari Medical reported Q3 revenue of $153.4M (+21.4% y/y and +5% sequentially), above consensus of $150.7M. NARI had previously set a Q3 sales outlook that implied ~$150M this ~$3M beat vs our expectations was driven by U.S. VTE and International sales growth. The full-year revenue outlook was... More
